14
Dec
2026

Menagen

Exhibitor at CPHI Middle East 2026 stand H1.R30
About Us

At Menagen, we are dedicated to helping patients with rare and difficult to manage diseases. 

Our high-tech production facility in Oman meets the highest global standards, based on international regulated authorities allowing us to bring new therapies to improve patients’ quality of life.

Our state-of-the-art facility enables us to accelerate the access of innovative medicines from regulated authorities to the MENAT region. Our focus is on local manufacturing, working with global partners, and always putting patients’ first.


  • Country/Region:
    Oman
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
Contact info
  • Alruasyl Industrial Alseeb, Muscat, Oman
Event information
CPHI Middle East 2026
  • 14 Dec 2026 - 16 Dec 2026
  • Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
  • Visit us at stand H1.R30

Products Featured at CPHI Middle East 2026

  • Darbegen

    Product Darbegen

    Indicated for Chronic Kidney Disease Anemia 
  • Ezirosy

    Product Ezirosy

    Treatment for Dyslipidemia 
  • Nitisinone Menagen

    Product Nitisinone Menagen

    Indicated for hereditary tyrosinemia type 1 
  • Renagen

    Product Renagen

    Indicated for hyperphosphatemia 
  • Ryzneuta

    Product Ryzneuta

    Indicated for chemotherapy induced neutropenia